John G Kelton1, Donald M Arnold, Shannon M Bates. Show Affiliations » 1. Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
Abstract
Entities: Chemical Disease
Mesh: See more » Antibodies/bloodAnticoagulants/adverse effectsAnticoagulants/therapeutic useAntithrombins/therapeutic useArthroplasty, Replacement, KneeChondroitin Sulfates/therapeutic useDermatan Sulfate/therapeutic useFondaparinuxHeparin/immunologyHeparin/metabolismHeparin, Low-Molecular-Weight/adverse effectsHeparitin Sulfate/therapeutic useHumansImmunoglobulin G/physiologyMaleMiddle AgedPlatelet Activation/immunologyPlatelet CountPlatelet Factor 4/immunologyPlatelet Factor 4/metabolismPolysaccharides/therapeutic usePractice Guidelines as TopicThrombocytopenia/chemically inducedThrombocytopenia/diagnosisThrombocytopenia/drug therapyVenous ThrombosisVitamin K/antagonists & inhibitors
Substances: See more » AntibodiesAnticoagulantsAntithrombinsHeparin, Low-Molecular-WeightImmunoglobulin GPolysaccharidesVitamin KDermatan SulfatePlatelet Factor 4HeparinChondroitin SulfatesHeparitin SulfatedanaparoidFondaparinux
Year: 2013 PMID: 23425166 DOI: 10.1056/NEJMct1206642
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245